Aug 07, 2024 / 09:00PM GMT
Operator
Hello, and thank you for standing by. Welcome to Allogene Therapeutics second quarter 2024 conference call. (Operator Instructions)
I would now like to turn the call over to Christine Cassiano. You may begin.
Christine Cassiano - Allogene Therapeutics Inc - Executive Vice President, Chief Corporate Affairs and Brand Strategy Officer
Thank you, operator, and welcome to all who have joined this call. After the market closed today, Allogene issued a press release that provides a business update and financial results for the second quarter of 2024. This press release and today's webcast are available on our website.
Following our prepared remarks, we will host a Q&A session. We recognize that historically questions have been multifaceted but note that we will endeavor to keep this call to under an hour. Joining me today are Dr. David Chang, President and Chief Executive Officer; Dr. Zachary Roberts, Executive Vice President of Research and Development and Chief Medical Officer; and Geoff Parker, Chief Financial Officer.
During today
Q2 2024 Allogene Therapeutics Inc Earnings Call Transcript
Aug 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers